Pfizer: Depression trials
The registry lists 32 Depression studies with Pfizer as lead sponsor. 0 are open to participants now and 14 have results posted.
Phase 1 2Phase 2 2Phase 3 18Phase 4 7No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01372150Phase 3Results posted
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01371734Phase 3Results posted
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDDCompletedNCT01371721Phase 3Results posted
- A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDDCompletedNCT01371708Phase 3Results posted
- Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)CompletedNCT01190514Phase 1Results posted
- Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With DepressionCompletedNCT01078298Phase 4Results posted
- Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of MidazolamCompletedNCT00952653Phase 4Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive DisorderCompletedNCT00669110Phase 2Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive DisorderCompletedNCT00619619Phase 2Results posted
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDDCompletedNCT00445679Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedNCT00406640Phase 3Results posted
- Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk ProgramCompletedNCT00401726Phase 4Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive DisorderCompletedNCT00384033Phase 3Results posted
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal WomenCompletedNCT00369343Phase 3Results posted
- A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)TerminatedNCT00939887Phase 1
- Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HClCompletedNCT00788944Phase 4
- Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious PatientsCompletedNCT00546923Phase 4
- Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining RemissionCompletedNCT00546494Phase 4
- Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
- Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy SubjectsCompletedNCT00329186Phase 3
- Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00329147Phase 3
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderCompletedNCT00300378Phase 3
- Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive DisorderCompletedNCT00277823Phase 3
- Study Evaluating Venlafaxine Extended Release in Elderly Depressed PatientsCompletedNCT00247429
- Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive DisorderCompletedNCT00242229Not applicable
- Study Evaluating Rhapsody Registry in Patients With Depression and AnxietyCompletedNCT00241397
- Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.CompletedNCT00225524Phase 3
- Study Evaluating Effexor XR for Major Depression.CompletedNCT00225511Phase 3
- Study Evaluating Effexor XR in Elderly Patients With Major Depression.CompletedNCT00225485Phase 3
- Study Evaluating Bifeprunox in Bipolar DepressionCompletedNCT00134459Phase 3
- Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive DisorderCompletedNCT00092911Phase 3
- Study Evaluating Venlafaxine ER in Recurrent DepressionCompletedNCT00046020Phase 4